Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-86.96	15.89	121.81
Graham Fair Price	271.36	2.57	0.69
PEG	-99.42	< 0.005	-0.72
Price/Book	14.56	0.44	0.38
Price/Cash Flow	-81.91	17.48	96.65
Prices/Earnings	-91.57	5.40	64.04
Price/Sales	24.59	1.79	1.44
Price/FCF	-81.91	17.48	96.65
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	598.07	0.12	0.02
Operating Margin	1512.67	0.12	< 0.005
ROA	1279.31	0.01	< 0.005
ROE	< 0.005	0.02	1259.28
ROIC	< 0.005	0.02	1099.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	< 0.005	9994.23
Dividends QOQ	-0.05	0.11	99.49
EBIT QOQ	-0.90	14.17	1481.15
EPS QOQ	-0.88	12.75	1341.82
FCF QOQ	1.39	5.48	293.95
Revenue QOQ	0.03	-0.06	84.85
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.78	5.41	43.02
Days Sales Outstanding (DSO)	88.45	91.38	3.32
Inventory Turnover	23.81	16.65	-30.08
Debt/Capitalization	0.10	0.11	10.11
Quick Ratio	1.04	1.20	15.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.77	3.80	0.72
Cash	0.20	0.35	73.00
Capex	-0.03	-0.03	-22.16
Free Cash Flow	0.01	0.10	538.03
Revenue	1.00	0.93	-7.38
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.10	1.26	15.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.87	0.92	-93.81
Naive Interpretation	Member

06 - Financial Health · Weak

Rating